Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens

PLoS One. 2012;7(10):e48512. doi: 10.1371/journal.pone.0048512. Epub 2012 Oct 29.

Abstract

Peptide immunotherapy using T-cell epitopes is expected to be an effective treatment for allergic diseases such as Japanese cedar (Cryptomeria japonica; Cj) pollinosis. To develop a treatment for pollen allergy by inducing oral tolerance, we generated genetically manipulated (GM) chickens by retroviral gene transduction, to produce a fusion protein of chicken egg white lysozyme and a peptide derived from seven dominant human T-cell epitopes of Japanese cedar pollen allergens (cLys-7crp). The transgene sequence was detected in all chickens transduced with the retroviral vector. Transduction efficiency in blood cells correlated to transgene expression. Western blot analysis revealed that cLys-7crp was expressed in the egg white of GM hens. Mice induced to develop allergic rhinitis by Cj pollinosis were fed with cLys-7crp-containing egg white produced by GM chickens. Total and Cj allergen (Cry j 1)-specific IgE levels were significantly decreased in allergic mice fed with cLys-7crp-containing egg white compared with allergic mice fed with normal egg white. These results suggest that oral administration of T-cell epitope-containing egg white derived from GM chickens is effective for the induction of immune tolerance as an allergy therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Allergens / genetics
  • Allergens / immunology*
  • Allergens / metabolism
  • Animals
  • Animals, Genetically Modified
  • Base Sequence
  • Blotting, Western
  • Chick Embryo
  • Chickens
  • Cryptomeria / immunology
  • Egg White*
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes, T-Lymphocyte / genetics
  • Epitopes, T-Lymphocyte / immunology*
  • Epitopes, T-Lymphocyte / metabolism
  • Humans
  • Immunoglobulin E / blood
  • Immunoglobulin E / immunology
  • Immunotherapy / methods*
  • Mice
  • Molecular Sequence Data
  • Muramidase / genetics
  • Muramidase / immunology
  • Muramidase / metabolism
  • NIH 3T3 Cells
  • Pollen / immunology
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / immunology*
  • Recombinant Fusion Proteins / metabolism
  • Rhinitis, Allergic, Seasonal / immunology*
  • Rhinitis, Allergic, Seasonal / therapy
  • Treatment Outcome

Substances

  • Allergens
  • Epitopes, T-Lymphocyte
  • Recombinant Fusion Proteins
  • Immunoglobulin E
  • Muramidase

Grants and funding

This work was supported in part by Grants-in-Aid for Scientific Research (nos. 18656245, 20360376, 23360372 and 23760753) from the Japan Society for the Promotion of Science and the Kieikai Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.